Home | Welcome to Contract Pharma   
Last Updated Friday, February 27 2015

Print

Breaking News

Related Searches: R&D Phase III Validation Development
January 6, 2015
Will support manufacturing and production of Argos immunotherapies   Read More »
January 5, 2015
To develop antisense drugs to treat gastrointestinal autoimmune disorders  Read More »
January 5, 2015
Aims to develop and commercialize next-gen (CAR) T cell immunotherapies  Read More »
January 5, 2015
Carroll responsible for all strategic corporate transactions  Read More »
January 5, 2015
Aims to develop and commercialize small molecule anti-fibrotic therapies  Read More »
January 5, 2015
Gains preclinical CMV vaccine candidate  Read More »
January 5, 2015
Will establish a research group focused on identifying novel therapeutic concepts  Read More »
January 5, 2015
Will combine capabilities aimed at high performance and max revenue potential  Read More »
January 5, 2015
Since 2009, Constantia Flexibles sales have grown 73%  Read More »
December 31, 2014
Observed sterility issue found during testing at 12 months   Read More »
December 30, 2014
First once-daily human (GLP-1) analogue shown to result in greater weight loss  Read More »
December 29, 2014
Adds new capabilities to produce specialty multi-web ECL constructions  Read More »
December 29, 2014
Will develop antibody for the treatment of a variety of inflammatory diseases  Read More »
December 29, 2014
SB742457 shown to hold promise in mild-to-moderate Alzheimer's disease  Read More »
December 29, 2014
New STR to be used in single-tablet regimen  Read More »



Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On